Research news news
With the rapid expansion of global business, newer suppliers with cheaper but possibly unreliable technologies have entered the marketplace to win orders from buyer firms by beating the price of their perfectly reliable (but expensive) competitors.
In contrast with sick people who need urgent medical attention, the clientele of preventive healthcare have a choice in whether to participate in the programs offered in their region. In order to maximize the total participation to a preventive care program, it is important to incorporate how potential clients choose the facilities to patronize.
Assessments of the trade-off theory have typically compared the present value of tax benefits to the present value of bankruptcy costs. We verify that this comparison overwhelmingly favors tax benefits, suggesting that firms are under-leveraged.
Drawing on the concept of organizational integration, we developed a typology that allows us to classify organizational IT applications and better understand, explain, and potentially predict their impacts. As a preliminary test of the typology, the empirical evidence of past research on the impacts of IT on organizational performance was reviewed.
With intense competition for research funding and status, universities need an objective way to rank their departments’ research performance, say the creators of a new tool designed to do just that.
The Neuro gained international renown as a centre of advanced epilepsy research and treatment thanks to the work of Dr. Penfield and such colleagues as the surgeon, Theodore Rasmussen, and the pioneer in electroencephalography (EEG), Herbert Jasper. Their illustrious example has inspired groundbreaking epilepsy research and treatment at the Neuro for more than 70 years.
Nearly one in five people suffers from the insidious and often devastating problem of chronic pain. That the problem persists, and is growing, is striking given the many breakthroughs in understanding the basic biology of pain over the past two decades. Research published online in Nature Medicine points to potential solutions.
A collaborative study by scientists at Baylor College of Medicine (BCM) and the Montreal Neurological Institute of McGill University, and published March 20 in the online, open access journal PLoS Biology, has discovered that mutations in the same gene that encodes part of the vital machinery of the mitochondrion can cause neurodegenerative disorders in both fruit flies and humans.
Collectively, institutional investors hold large ownership stakes in REITs. The traditional view is that institutions are both long-term and passive investors. The financial crisis beginning in 2007 provides an opportunity to analyze the investment choices of institutional investors before, during, and after the crisis.
This paper explores the topic of high-growth phenomenon and its agents. High-growth enterprises are primarily small and medium-sized firms that attain very high-growth rates for at least five years.
Nine McGill researchers were among the 132 newly awarded or renewed Canada Research Chairs just announced by the Honourable Gary Goodyear, Minister of State for Science and Technology. The McGill CRCs work in fields ranging from social statistics and family change to the cognitive neuroscience of attention and expectation.
In a study published in Nature, Alfonso Mucci, of the Department of Dept. of Earth and Planetary Sciences worked with colleagues from Concordia University to study the chemical makeup of sediment samples from oceans around the world to show how iron oxides can remove carbon dioxide from our atmosphere.
For those involved in managing the fallout from environmental disasters such as oil spills, it is essential to have tools that predict how the oil will move. McGill Engineering professor George Haller has worked with Prof. Josefina Olascoaga,from the University of Miami to develop a method that does not simply track: it actually forecasts major changes in the way that oil spills will move.
A recent study led by Gergely Lukacs, a professor at McGill University’s Faculty of Medicine, Dept. of Physiology, and published in the January issue of Cell, has shown that restoring normal function to the mutant gene product responsible for cystic fibrosis requires correcting two distinct structural defects. This finding could point to more effective therapeutic strategies for CF in the future.